KemPharm, Inc. announced that it has submitted a New Drug Application (NDA) under Section 505(b)(2) of the Federal Food, Drug...
Partner Therapeutics, Inc. (PTx) announced that its partner Nobelpharma received approval from the Japanese Pharmaceuticals and Medical Device Agency (PMDA) for the inhaled use of Leukine (sargramostim), branded in Japan as Sargmalin, to treat aPAP (Autoimmune pulmonary alveolar proteinosis)
Introduction: This guideline establishes clinical practice recommendations for positive airway pressure (PAP) treatment of obstructive sleep apnea (OSA) in adults and is intended for use in conjunction with other American Academy...
Vertex Pharmaceuticals Incorporated announced positive results from its Phase III program for the selective NaV1.8 inhibitor, VX 548, in the treatment of moderate-to-severe acute pain
Savara Inc.an orphan lung disease company, announced top line data from IMPALA, a pivotal Phase III clinical study evaluating Molgradex,...